Table: SymBio Pharmaceuticals - 6-MTH group results

SymBio Pharmaceuticals

10/08/2026 07:33

    Aug 10 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Jun 30, 2026        Jun 30, 2025      Dec 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            469 mln             646 mln            3.89      
                 (-27.3 pct)         (-49.7 pct)      (+197.5 pct)  
  Operating       loss 3.64           loss 2.15         loss 4.23   
  Recurring       loss 3.61           loss 2.34         loss 4.29   
  Net             loss 3.62           loss 2.37         loss 4.33   
  EPS          loss 50.89 yen      loss 49.35 yen    loss 72.81 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T